Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12241832rdf:typepubmed:Citationlld:pubmed
pubmed-article:12241832lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12241832lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:12241832lifeskim:mentionsumls-concept:C0027051lld:lifeskim
pubmed-article:12241832lifeskim:mentionsumls-concept:C0155626lld:lifeskim
pubmed-article:12241832lifeskim:mentionsumls-concept:C0003009lld:lifeskim
pubmed-article:12241832lifeskim:mentionsumls-concept:C0006938lld:lifeskim
pubmed-article:12241832lifeskim:mentionsumls-concept:C0126174lld:lifeskim
pubmed-article:12241832lifeskim:mentionsumls-concept:C0026565lld:lifeskim
pubmed-article:12241832lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12241832lifeskim:mentionsumls-concept:C0026538lld:lifeskim
pubmed-article:12241832lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:12241832lifeskim:mentionsumls-concept:C2698651lld:lifeskim
pubmed-article:12241832pubmed:issue9335lld:pubmed
pubmed-article:12241832pubmed:dateCreated2002-9-20lld:pubmed
pubmed-article:12241832pubmed:abstractTextACE inhibitors attenuate the detrimental effects of angiotensin II, and improve survival and reduce morbidity in patients with acute myocardial infarction and evidence of heart failure or left-ventricular dysfunction. Selective antagonism of the angiotensin type 1 receptor represents an alternative approach to inhibition of the renin-angiotensin system. We did a multicentre, randomised trial to test the hypothesis that the angiotensin II antagonist losartan would be superior or non-inferior to the ACE inhibitor captopril in decreasing all-cause mortality in high-risk patients after acute myocardial infarction.lld:pubmed
pubmed-article:12241832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12241832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12241832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12241832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12241832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12241832pubmed:languageenglld:pubmed
pubmed-article:12241832pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12241832pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12241832pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12241832pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12241832pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12241832pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12241832pubmed:statusMEDLINElld:pubmed
pubmed-article:12241832pubmed:monthSeplld:pubmed
pubmed-article:12241832pubmed:issn0140-6736lld:pubmed
pubmed-article:12241832pubmed:authorpubmed-author:KjekshusJohnJlld:pubmed
pubmed-article:12241832pubmed:authorpubmed-author:DicksteinKenn...lld:pubmed
pubmed-article:12241832pubmed:authorpubmed-author:OPTIMAAL...lld:pubmed
pubmed-article:12241832pubmed:issnTypePrintlld:pubmed
pubmed-article:12241832pubmed:day7lld:pubmed
pubmed-article:12241832pubmed:volume360lld:pubmed
pubmed-article:12241832pubmed:ownerNLMlld:pubmed
pubmed-article:12241832pubmed:authorsCompleteYlld:pubmed
pubmed-article:12241832pubmed:pagination752-60lld:pubmed
pubmed-article:12241832pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12241832pubmed:meshHeadingpubmed-meshheading:12241832...lld:pubmed
pubmed-article:12241832pubmed:meshHeadingpubmed-meshheading:12241832...lld:pubmed
pubmed-article:12241832pubmed:meshHeadingpubmed-meshheading:12241832...lld:pubmed
pubmed-article:12241832pubmed:meshHeadingpubmed-meshheading:12241832...lld:pubmed
pubmed-article:12241832pubmed:meshHeadingpubmed-meshheading:12241832...lld:pubmed
pubmed-article:12241832pubmed:meshHeadingpubmed-meshheading:12241832...lld:pubmed
pubmed-article:12241832pubmed:meshHeadingpubmed-meshheading:12241832...lld:pubmed
pubmed-article:12241832pubmed:meshHeadingpubmed-meshheading:12241832...lld:pubmed
pubmed-article:12241832pubmed:meshHeadingpubmed-meshheading:12241832...lld:pubmed
pubmed-article:12241832pubmed:meshHeadingpubmed-meshheading:12241832...lld:pubmed
pubmed-article:12241832pubmed:meshHeadingpubmed-meshheading:12241832...lld:pubmed
pubmed-article:12241832pubmed:meshHeadingpubmed-meshheading:12241832...lld:pubmed
pubmed-article:12241832pubmed:meshHeadingpubmed-meshheading:12241832...lld:pubmed
pubmed-article:12241832pubmed:year2002lld:pubmed
pubmed-article:12241832pubmed:articleTitleEffects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.lld:pubmed
pubmed-article:12241832pubmed:affiliationUniversity of Bergen, Cardiology Division, Central Hospital in Rogaland, 4011 Stavanger, Norway. trout.@online.nolld:pubmed
pubmed-article:12241832pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12241832pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12241832pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:12241832pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:12241832pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12241832lld:pubmed